Abstract
Shelter-in-place mandates and closure of non-essential businesses have been central to COVID-19 response strategies including in Toronto, Canada. Approximately half of the working population in Canada are employed in occupations that do not allow for remote work suggesting potentially limited impact of some of the strategies proposed to mitigate COVID-19 acquisition and onward transmission risks and associated morbidity and mortality. We compared per-capita rates of COVID-19 cases and deaths from January 23, 2020 to January 24, 2021, across neighborhoods in Toronto by proportion of the population working in essential services. We used person-level data on laboratory-confirmed COVID-19 community cases (N=74,477) and deaths (N=2319), and census data for neighborhood-level attributes. Cumulative per-capita rates of COVID-19 cases and deaths were 3-fold and 2.5-fold higher, respectively, in neighborhoods with the highest versus lowest concentration of essential workers. Findings suggest that the population who continued to serve the essential needs of society throughout COVID-19 shouldered a disproportionate burden of transmission and deaths. Taken together, results signal the need for active intervention strategies to complement restrictive measures to optimize both the equity and effectiveness of COVID-19 responses.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Canadian Institutes of Health Research (grant no. VR5-172683).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Toronto Health Sciences Research Ethics Board (protocol no. 39253) approved the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email Addresses: Amrita Rao: arao24{at}jhu.edu, Huiting Ma: huiting.ma{at}unityhealth.to, Gary Moloney: gary.moloney{at}unityhealth.to, Jeffrey C Kwong: jeff.kwong{at}utoronto.ca, Peter Jüni: peter.juni{at}utoronto.ca, Beate Sander: beate.sander{at}uhnresearch.ca, Rafal Kustra: r.kustra{at}utoronto.ca, Stefan D Baral: sbaral{at}jhu.edu, Sharmistha Mishra: sharmistha.mishra{at}utoronto.ca
Data Availability
Data used in this study can be made available upon request.
List of Abbreviations
- CCM+
- Case and Contact Management Solutions
- DA
- dissemination areas
- IQR
- interquartile range
